Feasibility Study for Repurposing RET Inhibitors
NCT07146893
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
NOT_YET_RECRUITING
Status
7
Enrollment
OTHER
Sponsor class
Conditions
Cachexia-Anorexia Syndrome
Interventions
DRUG:
Selpercatinib
OTHER:
Strength Assessment
Sponsor
University of Oklahoma
Collaborators
[object Object]